Healthcare -
Biotechnology - NASDAQ - US
$ 2.2
7.84 %
$ 37 M
Market Cap
-0.5
P/E
OCX - COMMON STOCK
Common Stock OCX - OncoCyte Corporation
310 M
LAST VALUE
10.76%
2 YEAR CAGR
32.94%
5 YEAR CAGR
35.03%
10 YEAR CAGR